Scott Shannon: Cannabidiol in the Treatment of Anxiety - A Large Case Series

Cannabidiol (CBD) is presented as a therapeutic tool for anxiety, PTSD, and sleep disturbances based on a large clinical case series. By leveraging the body's endocannabinoid system, CBD demonstrates a calming effect on the central nervous system without the intoxicating properties of THC. Clinical observations from the Wholeness Center suggest therapeutic potential for easing anxiety-related symptoms, often at doses around 25 to 50 milligrams per day. The presentation emphasizes that CBD serves as a distinct alternative to standard psychiatric medications, particularly for patients seeking to avoid potential side effects. Evidence from the case series indicates that CBD is generally well-tolerated, with minimal reportable adverse reactions, making it an increasingly viable option for psychiatric care.